237 related articles for article (PubMed ID: 8197043)
1. Application of actigraphy in the clinical setting: use in children with attention-deficit hyperactivity disorder.
Miller LG; Kraft IA
Pharmacotherapy; 1994; 14(2):219-23. PubMed ID: 8197043
[TBL] [Abstract][Full Text] [Related]
2. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
[TBL] [Abstract][Full Text] [Related]
3. Response to growth hormone in attention deficit hyperactivity disorder: effects of methylphenidate and pemoline therapy.
Rao JK; Julius JR; Breen TJ; Blethen SL
Pediatrics; 1998 Aug; 102(2 Pt 3):497-500. PubMed ID: 9685452
[TBL] [Abstract][Full Text] [Related]
4. A controlled trial of the methylphenidate transdermal system on before-school functioning in children with attention-deficit/hyperactivity disorder.
Wilens TE; Hammerness P; Martelon M; Brodziak K; Utzinger L; Wong P
J Clin Psychiatry; 2010 May; 71(5):548-56. PubMed ID: 20492851
[TBL] [Abstract][Full Text] [Related]
5. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
6. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
Yang P; Hsu HY; Chiou SS; Chao MC
Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
[TBL] [Abstract][Full Text] [Related]
8. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
9. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
Bricard C; Boidein F
Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
[TBL] [Abstract][Full Text] [Related]
10. Psychosocial treatments for attention-deficit/hyperactivity disorder in children.
Barkley RA
J Clin Psychiatry; 2002; 63 Suppl 12():36-43. PubMed ID: 12562060
[TBL] [Abstract][Full Text] [Related]
11. Attention-deficit/hyperactivity disorder: a life-span perspective.
Biederman J
J Clin Psychiatry; 1998; 59 Suppl 7():4-16. PubMed ID: 9680048
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological treatment of attention deficit disorder, residual type (ADD,RT, "minimal brain dysfunction," "hyperactivity") in adults.
Wender PH; Wood DR; Reimherr FW
Psychopharmacol Bull; 1985; 21(2):222-31. PubMed ID: 3923527
[No Abstract] [Full Text] [Related]
13. Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD.
Flapper BC; Schoemaker MM
Dev Med Child Neurol; 2008 Apr; 50(4):294-9. PubMed ID: 18352997
[TBL] [Abstract][Full Text] [Related]
14. The use of stimulant medication with children.
Phillips S
J Dev Behav Pediatr; 1989 Dec; 10(6):319-20. PubMed ID: 2600187
[No Abstract] [Full Text] [Related]
15. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
[TBL] [Abstract][Full Text] [Related]
16. Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial.
Akhondzadeh S; Tavakolian R; Davari-Ashtiani R; Arabgol F; Amini H
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):841-5. PubMed ID: 12921918
[TBL] [Abstract][Full Text] [Related]
17. Pediatricians' reported practices in the assessment and treatment of attention deficit disorders.
Copeland L; Wolraich M; Lindgren S; Milich R; Woolson R
J Dev Behav Pediatr; 1987 Aug; 8(4):191-7. PubMed ID: 3611359
[TBL] [Abstract][Full Text] [Related]
18. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.
Power TJ; Mautone JA; Manz PH; Frye L; Blum NJ
Pediatrics; 2008 Jan; 121(1):e65-72. PubMed ID: 18166546
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy of attention-deficit/hyperactivity disorder in adults.
Wender PH
J Clin Psychiatry; 1998; 59 Suppl 7():76-9. PubMed ID: 9680056
[TBL] [Abstract][Full Text] [Related]
20. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
